{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:58:13Z","timestamp":1773853093445,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-08108-1","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:56:57Z","timestamp":1752141417000},"page":"1145-1153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Counseling prior to cfDNA screening: are we giving the right numbers?"],"prefix":"10.1007","volume":"312","author":[{"given":"Tania","family":"Elger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Sonek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Prodan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hoopmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Grati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1497-5143","authenticated-orcid":false,"given":"Karl Oliver","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"8108_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00404-022-06477-5","volume":"305","author":"KO Kagan","year":"2022","unstructured":"Kagan KO, Sonek J, Kozlowski P (2022) Antenatal screening for chromosomal abnormalities. Arch Gynecol Obstet 305:825\u2013835. https:\/\/doi.org\/10.1007\/s00404-022-06477-5","journal-title":"Arch Gynecol Obstet"},{"key":"8108_CR2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.3390\/diagnostics13152570","volume":"13","author":"SS Jayashankar","year":"2023","unstructured":"Jayashankar SS, Nasaruddin ML, Hassan MF et al (2023) Non-invasive prenatal testing (NIPT): reliability, challenges, and future directions. Diagnostics 13:2570. https:\/\/doi.org\/10.3390\/diagnostics13152570","journal-title":"Diagnostics"},{"key":"8108_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/uog.15783","volume":"47","author":"MM Gil","year":"2016","unstructured":"Gil MM, Revello R, Poon LC et al (2016) Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test. Ultrasound Obstet Gynecol 47:45\u201352. https:\/\/doi.org\/10.1002\/uog.15783","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8108_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-025-02736-y","author":"C Warton","year":"2025","unstructured":"Warton C, Vears DF (2025) Healthcare professionals\u2019 perspectives on and experiences with non-invasive prenatal testing: a systematic review. Hum Genet. https:\/\/doi.org\/10.1007\/s00439-025-02736-y","journal-title":"Hum Genet"},{"key":"8108_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s12884-022-05110-2","volume":"22","author":"SA Kristalijn","year":"2022","unstructured":"Kristalijn SA, White K, Eerbeek D et al (2022) Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands. BMC Pregnancy Childbirth 22:782. https:\/\/doi.org\/10.1186\/s12884-022-05110-2","journal-title":"BMC Pregnancy Childbirth"},{"key":"8108_CR6","unstructured":"Bundesausschuss G Mutterschaftsrichtlinien. https:\/\/www.g-ba.de\/richtlinien\/19\/"},{"key":"8108_CR7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/jgc4.1839","volume":"33","author":"A Perrot","year":"2024","unstructured":"Perrot A, Clarke A, Vassy C, Horn R (2024) Women\u2019s preferences for NIPT as a first-line test in England and France: challenges for genetic counseling practices. J Genet Couns 33:1204\u20131214. https:\/\/doi.org\/10.1002\/jgc4.1839","journal-title":"J Genet Couns"},{"key":"8108_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/a-2028-8108","volume":"44","author":"B Eiben","year":"2023","unstructured":"Eiben B, Glaubitz R, Winkler T, Merz E (2023) First-trimester screening in germany after the introduction of NIPT as a general health insurance benefit. Ultraschall Med - Eur J Ultrasound 44:327\u2013328. https:\/\/doi.org\/10.1055\/a-2028-8108","journal-title":"Ultraschall Med - Eur J Ultrasound"},{"key":"8108_CR9","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.gim.2022.03.019","volume":"24","author":"NC Rose","year":"2022","unstructured":"Rose NC, Barrie ES, Malinowski J et al (2022) Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies. Genet Med 24:1379\u20131391. https:\/\/doi.org\/10.1016\/j.gim.2022.03.019","journal-title":"Genet Med"},{"key":"8108_CR10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/gim.2018.22","volume":"20","author":"GE Palomaki","year":"2018","unstructured":"Palomaki GE, Kloza EM (2018) Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing. Genet Med 20:1312\u20131323. https:\/\/doi.org\/10.1038\/gim.2018.22","journal-title":"Genet Med"},{"key":"8108_CR11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/pd.6448","volume":"43","author":"K L\u00fcthgens","year":"2023","unstructured":"L\u00fcthgens K, H\u00e4big K, Sonek J, Kagan KO (2023) Screen-positive rate in cell free DNA screening for trisomy 21. Prenat Diagn 43:1536\u20131543. https:\/\/doi.org\/10.1002\/pd.6448","journal-title":"Prenat Diagn"},{"key":"8108_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/pd.4804","volume":"36","author":"Y Yaron","year":"2016","unstructured":"Yaron Y (2016) The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn 36:391\u2013396. https:\/\/doi.org\/10.1002\/pd.4804","journal-title":"Prenat Diagn"},{"key":"8108_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280858","volume":"19","author":"J Gazdarica","year":"2024","unstructured":"Gazdarica J, Forgacova N, Sladecek T et al (2024) Insights into non-informative results from non-invasive prenatal screening through gestational age, maternal BMI, and age analyses. PLoS ONE 19:e0280858. https:\/\/doi.org\/10.1371\/journal.pone.0280858","journal-title":"PLoS ONE"},{"key":"8108_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ajog.2023.11.1240","volume":"230","author":"Y Raymond","year":"2024","unstructured":"Raymond Y, Fernando S, Menezes M et al (2024) Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results. Am J Obstet Gynecol 230:381\u2013389. https:\/\/doi.org\/10.1016\/j.ajog.2023.11.1240","journal-title":"Am J Obstet Gynecol"},{"key":"8108_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/uog.29098","volume":"64","author":"DL Rolnik","year":"2024","unstructured":"Rolnik DL, Raymond Y, Lee T et al (2024) Uterine fibroids and non-informative cell-free DNA screening results. Ultrasound Obstet Gynecol 64:463\u2013469. https:\/\/doi.org\/10.1002\/uog.29098","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8108_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00439-025-02736-y","volume":"144","author":"C Warton","year":"2025","unstructured":"Warton C, Vears DF (2025) Healthcare professionals\u2019 perspectives on and experiences with non-invasive prenatal testing: a systematic review. Hum Genet 144:343\u2013374. https:\/\/doi.org\/10.1007\/s00439-025-02736-y","journal-title":"Hum Genet"},{"key":"8108_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/pd.5620","volume":"40","author":"L Hui","year":"2020","unstructured":"Hui L, Bianchi DW (2020) Fetal fraction and noninvasive prenatal testing: what clinicians need to know. Prenat Diagn 40:155\u2013163. https:\/\/doi.org\/10.1002\/pd.5620","journal-title":"Prenat Diagn"},{"key":"8108_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/pd.6271","volume":"42","author":"FR Grati","year":"2022","unstructured":"Grati FR, Bestetti I, Siero DD et al (2022) Positive predictive values and outcomes for uninformative cell-free DNA tests: an Italian multicentric Cytogenetic and cytogenomic Audit of diagnOstic testing (ICARO study). Prenat Diagn 42:1575\u20131586. https:\/\/doi.org\/10.1002\/pd.6271","journal-title":"Prenat Diagn"},{"key":"8108_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1055\/a-2280-4756","volume":"46","author":"C von Kaisenberg","year":"2024","unstructured":"von Kaisenberg C, Kozlowski P, Kagan K-O et al (2024) Firsttrimester diagnosis and therapy @ 11\u201313 +6 weeks of gestation \u2013 part 1. Ultraschall Med - Eur J Ultrasound 46:36\u201348. https:\/\/doi.org\/10.1055\/a-2280-4756","journal-title":"Ultraschall Med - Eur J Ultrasound"},{"key":"8108_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1055\/a-2280-4887","volume":"46","author":"C von Kaisenberg","year":"2024","unstructured":"von Kaisenberg C, Kozlowski P, Kagan K-O et al (2024) Firsttrimester diagnosis and therapy @ 11\u201313 +6 weeks of gestation \u2013 Part 2. Ultraschall Med - Eur J Ultrasound 46:145\u2013161. https:\/\/doi.org\/10.1055\/a-2280-4887","journal-title":"Ultraschall Med - Eur J Ultrasound"},{"key":"8108_CR21","unstructured":"Current ACOG Guidance. NIPT Summary of Recommendations. https:\/\/www.acog.org\/advocacy\/policy-priorities\/non-invasive-prenatal-testing\/current-acog-guidance. Accessed 4 May 2025"},{"key":"8108_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","volume":"94","author":"HS Cuckle","year":"1987","unstructured":"Cuckle HS, Wald NJ, Thompson SG (1987) Estimating a woman\u2019s risk of having a pregnancy associated with Down\u2019s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94:387\u2013402","journal-title":"Br J Obstet Gynaecol"},{"key":"8108_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1469-0705.1999.13030167.x","volume":"13","author":"RJ Snijders","year":"1999","unstructured":"Snijders RJ, Sundberg K, Holzgreve W et al (1999) Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 13:167\u2013170. https:\/\/doi.org\/10.1046\/j.1469-0705.1999.13030167.x","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8108_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000264259","volume":"10","author":"RJM Snijders","year":"1995","unstructured":"Snijders RJM, Sebire NJ, Nicolaides KH (1995) Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 10:356\u2013367. https:\/\/doi.org\/10.1159\/000264259","journal-title":"Fetal Diagn Ther"},{"key":"8108_CR25","unstructured":"Bundesamt S Lebendgeborene nach der Geburtenfolge und dem Geburtsjahr der Mutter in Deutschland. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Bevoelkerung\/Geburten\/Tabellen\/geburtsjahr-geburtenfolge.html"},{"key":"8108_CR26","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/pd.6238","volume":"42","author":"F Bardi","year":"2022","unstructured":"Bardi F, Bet BB, Pajkrt E et al (2022) Additional value of advanced ultrasonography in pregnancies with two inconclusive cell-free DNA draws. Prenat Diagn 42:1358\u20131367. https:\/\/doi.org\/10.1002\/pd.6238","journal-title":"Prenat Diagn"},{"key":"8108_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.semperi.2015.11.003","volume":"40","author":"H Cuckle","year":"2016","unstructured":"Cuckle H, Maymon R (2016) Development of prenatal screening\u2014A historical overview. Semin Perinatol 40:12\u201322. https:\/\/doi.org\/10.1053\/j.semperi.2015.11.003","journal-title":"Semin Perinatol"},{"key":"8108_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/grf.0000000000000906","volume":"68","author":"C Baptiste","year":"2025","unstructured":"Baptiste C, Grati FR, Levy B (2025) Chromosomal mosaicism in the placenta. Clin Obstet Gynecol 68:130\u2013138. https:\/\/doi.org\/10.1097\/grf.0000000000000906","journal-title":"Clin Obstet Gynecol"},{"key":"8108_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1159\/000510069","volume":"47","author":"KO Kagan","year":"2020","unstructured":"Kagan KO, Hoopmann M, Pfaff T et al (2020) First trimester screening for common trisomies and microdeletion 22q11.2 syndrome using cell-free DNA: a prospective clinical study. Fetal Diagn Ther 47:841\u2013852. https:\/\/doi.org\/10.1159\/000510069","journal-title":"Fetal Diagn Ther"},{"key":"8108_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/uog.18905","volume":"51","author":"KO Kagan","year":"2018","unstructured":"Kagan KO, Sroka F, Sonek J et al (2018) First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial. Ultrasound Obstet Gynecol 51:437\u2013444. https:\/\/doi.org\/10.1002\/uog.18905","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8108_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/pd.6755","volume":"45","author":"F Scott","year":"2025","unstructured":"Scott F, Han MP, de Ferreira AEG et al (2025) Strategies to detect chromosomal anomalies not identified by NIPT. Prenat Diagn 45:464\u2013472. https:\/\/doi.org\/10.1002\/pd.6755","journal-title":"Prenat Diagn"},{"key":"8108_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/uog.17533","volume":"51","author":"MI Srebniak","year":"2018","unstructured":"Srebniak MI, Joosten M, Knapen MFCM et al (2018) Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta-analysis. Ultrasound Obstet Gynecol 51:445\u2013452. https:\/\/doi.org\/10.1002\/uog.17533","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8108_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/uog.27667","volume":"64","author":"K Gadsb\u00f8ll","year":"2024","unstructured":"Gadsb\u00f8ll K, Vogel I, Kristensen SE et al (2024) Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT. Ultrasound Obstet Gynecol 64:470\u2013479. https:\/\/doi.org\/10.1002\/uog.27667","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8108_CR34","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/nejmoa1203382","volume":"367","author":"RJ Wapner","year":"2012","unstructured":"Wapner RJ, Martin CL, Levy B et al (2012) Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 367:2175\u20132184. https:\/\/doi.org\/10.1056\/nejmoa1203382","journal-title":"N Engl J Med"},{"key":"8108_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/uog.17283","volume":"49","author":"M Santorum","year":"2017","unstructured":"Santorum M, Wright D, Syngelaki A et al (2017) Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstetrics Amp Gynecol 49:714\u2013720. https:\/\/doi.org\/10.1002\/uog.17283","journal-title":"Ultrasound Obstetrics Amp Gynecol"},{"key":"8108_CR36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/uog.15829","volume":"48","author":"P Wagner","year":"2016","unstructured":"Wagner P, Sonek J, Hoopmann M et al (2016) First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan. Ultrasound Obstet Gynecol 48:446\u2013451. https:\/\/doi.org\/10.1002\/uog.15829","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8108_CR37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/pd.2149","volume":"28","author":"KO Kagan","year":"2008","unstructured":"Kagan KO, Anderson JM, Anwandter G et al (2008) Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation. Prenat Diagn 28:1209\u20131213. https:\/\/doi.org\/10.1002\/pd.2149","journal-title":"Prenat Diagn"},{"key":"8108_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/pd.6393","author":"F Bardi","year":"2023","unstructured":"Bardi F, Kagan KO, Bilardo CM (2023) First-trimester screening strategies: a balance between costs, efficiency and diagnostic yield. Prenat Diagn. https:\/\/doi.org\/10.1002\/pd.6393","journal-title":"Prenat Diagn"},{"key":"8108_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.188","volume":"126","author":"NJ Wald","year":"2017","unstructured":"Wald NJ, Huttly WJ, Bestwick JP et al (2017) Prenatal reflex DNA screening for trisomies 21, 18, and 13. Genet Med 126:e31. https:\/\/doi.org\/10.1038\/gim.2017.188","journal-title":"Genet Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08108-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:32:28Z","timestamp":1757475148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08108-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["8108"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08108-1","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Karl Oliver Kagan, Tania Elger, and Jiri Sonek are editors of Archives of Gynecology and Obstetrics. Karl Oliver Kagan is the Editor-in-Chief. Francesca Romana Grati is full-time employee of Menarini Silicon Biosystems.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is based on the German birth statistics in 2023. Therefore, an ethical approval is not necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have agreed to publish this manuscript in Archives of Gynecology and Obstetrics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}